SECTRAL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sectral, and what generic alternatives are available?
Sectral is a drug marketed by Promius Pharma and is included in one NDA.
The generic ingredient in SECTRAL is acebutolol hydrochloride. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acebutolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sectral
A generic version of SECTRAL was approved as acebutolol hydrochloride by ANI PHARMS on October 18th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SECTRAL?
- What are the global sales for SECTRAL?
- What is Average Wholesale Price for SECTRAL?
Summary for SECTRAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 70 |
| Clinical Trials: | 3 |
| Patent Applications: | 4,241 |
| What excipients (inactive ingredients) are in SECTRAL? | SECTRAL excipients list |
| DailyMed Link: | SECTRAL at DailyMed |
Recent Clinical Trials for SECTRAL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre Hospitalier Universitaire de Saint Etienne | Phase 4 |
| University Hospital, Montpellier | Phase 3 |
| Mayo Clinic | N/A |
US Patents and Regulatory Information for SECTRAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promius Pharma | SECTRAL | acebutolol hydrochloride | CAPSULE;ORAL | 018917-001 | Dec 28, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Promius Pharma | SECTRAL | acebutolol hydrochloride | CAPSULE;ORAL | 018917-003 | Dec 28, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SECTRAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Promius Pharma | SECTRAL | acebutolol hydrochloride | CAPSULE;ORAL | 018917-001 | Dec 28, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| Promius Pharma | SECTRAL | acebutolol hydrochloride | CAPSULE;ORAL | 018917-003 | Dec 28, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| Promius Pharma | SECTRAL | acebutolol hydrochloride | CAPSULE;ORAL | 018917-003 | Dec 28, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| Promius Pharma | SECTRAL | acebutolol hydrochloride | CAPSULE;ORAL | 018917-001 | Dec 28, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SECTRAL
See the table below for patents covering SECTRAL around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Cyprus | 723 | Benzene derivatives | ⤷ Sign Up |
| Netherlands | 6818289 | ⤷ Sign Up | |
| Iceland | 860 | ⤷ Sign Up | |
| Norway | 125183 | ⤷ Sign Up | |
| Ireland | 32898 | BENZENE DERIVATIVES | ⤷ Sign Up |
| Ireland | 32174 | NEW COMPOSITIONS OF MATTER | ⤷ Sign Up |
| Denmark | 129034 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
